Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100045851Phase 4Recruiting
Phase 4, randomised trial in critical illness comparing Remimazolam group, Midazolam group and Propofol group (3 arms). Primary endpoint: percentage of target sedation time. Started Apr 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100045851.